Speaking via livestream at the J.P. Morgan Conference, FDA Commissioner Dr. Scott Gottlieb announced a broad restructuring of the Office of New Drugs to make the approval process more structured, with data coming from the cloud.
FDA launches new office to rethink how drugs are reviewed
